A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

Inclusion Criteria: * 18-65 years old female patients with cyclomastopathy who signed a written informed consent. * The subjects voluntarily entered the clinical observation whom are hospitalized patients or outpatients with good compliance. * They have specific symptoms, such as distending pain of the breast, stabbing pain, dull pain and radiating pain. * They have specific physical sign, for example, we can touch block gland, granular, nodular or cord like glands and etc.. * Breast ultrasound or molybdenum target show I-III class by Breast Imaging Reporting and Data System. Exclusion Criteria: * Women who are pregnant or lactating, and who has the history of periarthritis of shoulder. * Excluding breast fibrocellular tumor, breast cancer and other breast diseases. * Patients with poor self coordination, mentally retarded patients, or have cardiovascular and cerebrovascular disease, severe organic disease, as well as the hematopoietic system disease or mental illness. * Be judged as over middle degree depression by the Hamilton's depression scale. * Allergic constitution patients, and people who are allergic to a variety of drugs. * Any medical history which may interfere with the test results or increase the risk of patients according to the investigators. * Patients who have received treatment of other diseases, and those treatment methods and targets may have an impact on the indicators of this study.